Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001081255 | SCV000639170 | likely benign | Oligodontia-cancer predisposition syndrome | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000545621 | SCV001805180 | likely benign | not provided | 2018-08-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002265793 | SCV002548343 | likely benign | not specified | 2022-05-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002431610 | SCV002742652 | likely benign | Hereditary cancer-predisposing syndrome | 2020-06-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000545621 | SCV004220142 | benign | not provided | 2023-04-23 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV001081255 | SCV005403195 | benign | Oligodontia-cancer predisposition syndrome | 2024-07-11 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV004541692 | SCV004774712 | likely benign | AXIN2-related disorder | 2024-02-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |